Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats.
about
Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays.Nigella sativa Oil Reduces Extrapyramidal Symptoms (EPS)-Like Behavior in Haloperidol-Treated Rats.Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats.
P2860
Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats.
@ast
Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats.
@en
type
label
Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats.
@ast
Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats.
@en
prefLabel
Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats.
@ast
Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats.
@en
P2093
P356
P1433
P1476
Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats.
@en
P2093
P2888
P304
P356
10.1007/S002130000570
P577
2001-01-01T00:00:00Z
P6179
1020377993